Skip to Main Content

Dr. Jennifer Cohen Price is a gastroenterologist and hepatologist, an expert in liver disease. She specializes in caring for patients awaiting liver transplants.

In her research, Price addresses liver disease in HIV-positive patients. She also studies viral hepatitis and nonalcoholic fatty liver disease.

Price earned her medical degree at Johns Hopkins School of Medicine and continued her medical training there, completing a residency, a fellowship in gastroenterology and hepatology, and a fellowship in transplant hepatology. She earned her doctorate degree in clinical investigation at Johns Hopkins School of Public Health.

Price is a fellow of the American College of Physicians. She is a member of the American College of Gastroenterology, American Gastroenterological Association and American Association for the Study of Liver Diseases.

  • Education

    Johns Hopkins University School of Medicine, 2004

  • Residencies

    Johns Hopkins Hospital, Internal Medicine, 2007

  • Fellowships

    Johns Hopkins Hospital, Gastroenterology and Hepatology, 2011

    Johns Hopkins Hospital, Transplant Hepatology, 2012

  • Board Certifications

    Transplant Hepatology, American Board of Internal Medicine

    Internal Medicine, American Board of Internal Medicine

    Gastroenterology, American Board of Internal Medicine

  • Academic Title

    Associate Professor

Where I see patients (3)

    My reviews

    4.9

    Overall Experience
    113 Ratings
    Explained things in a way that was easy to understand
    113 Ratings
    Did the doctor pay attention to your concerns
    112 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    102 Ratings
    Knew the important information about your medical history
    111 Ratings
    The provider showed respect for what you had to say
    112 Ratings
    The provider spent enough time with me
    113 Ratings
    Decorative Caduceus

    HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

    Time (in days) to first of any of the following events: death or graft failure or SAE or HIV breakthrough or opportunistic infection

    Recruiting

    Decorative Caduceus

    Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

    Prevalence of hepatic steatosis in PLWH will be reported as the number of participants with hepatic steatosis, defined by controlled attenuation parameter (CAP) ≥263 dB/m, over the total number of participants assessed.

    Recruiting

    Decorative Caduceus

    Rapid HCV Treatment Access for Persons Who Use Drugs

    Proportion of participants who start HCV treatment in each arm.

    Recruiting

    Share